Why it is important to include unpublished data in systematic reviews.
نویسندگان
چکیده
It is known that studies with statistically significant results have a higher probability to be published (publication bias). Therefore, studies with no statistically significant differences (or not favoring the investigational drug) may not be found in commonly accessed databases and remain unpublished. Moreover, unpublished data may also refer to information that are not included in study reports published in scientific journals but that may be important to estimate study outcomes. Retrieving unpublished evidence represents a compelling challenge for researchers, and in the present paper we explore how to do it.
منابع مشابه
The Development of a Critical Appraisal Tool for Use in Systematic Reviews: Addressing Questions of Prevalence
Background Recently there has been a significant increase in the number of systematic reviews addressing questions of prevalence. Key features of a systematic review include the creation of an a priori protocol, clear inclusion criteria, a structured and systematic search process, critical appraisal of studies, and a formal process of data extraction followed by methods to synthesize, or combin...
متن کاملSearch for unpublished data by systematic reviewers: an audit
OBJECTIVES We audited a selection of systematic reviews published in 2013 and reported on the proportion of reviews that researched for unpublished data, included unpublished data in analysis and assessed for publication bias. DESIGN Audit of systematic reviews. DATA SOURCES We searched PubMed and Ovid MEDLINE In-Process & Other Non-Indexed Citations between 1 January 2013 and 31 December 2...
متن کاملStrategies for obtaining unpublished drug trial data: a qualitative interview study
BACKGROUND Authors of systematic reviews have difficulty obtaining unpublished data for their reviews. This project aimed to provide an in-depth description of the experiences of authors in searching for and gaining access to unpublished data for their systematic reviews, and to give guidance on best practices for identifying, obtaining and using unpublished data. METHODS This is a qualitativ...
متن کاملEffect of reporting bias onmeta-analyses of drug trials: reanalysis of meta-analyses OPEN ACCESS
Objective To investigate the effect of including unpublished trial outcome data obtained from the Food and Drug Administration (FDA) on the results of meta-analyses of drug trials. Design Reanalysis of meta-analyses. Data sources Drug trials with unpublished outcome data for new molecular entities that were approved by the FDA between 2001 and 2002 were identified. For each drug, eligible syste...
متن کاملSome Notes on Critical Appraisal of Prevalence Studies; Comment on: “The Development of a Critical Appraisal Tool for Use in Systematic Reviews Addressing Questions of Prevalence”
Decisions in healthcare should be based on information obtained according to the principles of Evidence-Based Medicine (EBM). An increasing number of systematic reviews are published which summarize the results of prevalence studies. Interpretation of the results of these reviews should be accompanied by an appraisal of the methodological quality of the included data and studies. The critical a...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Epidemiology and psychiatric sciences
دوره 20 2 شماره
صفحات -
تاریخ انتشار 2011